Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 92820 [2016-30523]
Download as PDF
<![CDATA[
92820
Federal Register / Vol. 81, No. 244 / Tuesday, December 20, 2016 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–30521 Filed 12–19–16; 8:45 am]
BILLING CODE 4163–19–P
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2016–30523 Filed 12–19–16; 8:45 am]
BILLING CODE 4163–18–P
mstockstill on DSK3G9T082PROD with NOTICES
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 11:00 a.m.–1:00 p.m.,
EST, January 23, 2017.
Place: Teleconference.
Status: The meeting is open to the
public; the toll free dial in number is 1–
877–951–7311 with a pass code of
4530516.
Purpose: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the
Director, OID; and the Directors of the
National Center for Immunization and
Respiratory Diseases, the National
Center for Emerging and Zoonotic
Infectious Diseases, and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, in the
following areas: Strategies, goals, and
priorities for programs; research within
the national centers; and overall
strategic direction and focus of OID and
the national centers.
Matters for Discussion: Topics to be
discussed during the teleconference
include (1) discussion and vote on the
Food Safety Modernization Act
Surveillance Working Group Annual
Report to the Secretary of Health and
Human Services and (2) a report back
from a recent external review of CDC’s
advanced molecular detection activities.
The agenda and any supplemental
material will be available at
www.cdc.gov/oid/BSC/
meetingschedule.html after January 16.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated
Federal Officer, OID, CDC, 1600 Clifton
Road NE., Mailstop D10, Atlanta,
Georgia 30333, Telephone: (404) 639–
4461.
VerDate Sep<11>2014
19:36 Dec 19, 2016
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention announces the
following committee meeting:
Time and Date: 11:00 a.m.–2:00 p.m.,
EST, January 25, 2017.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public. The public
is welcome to submit written comments
in advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference at the USA toll-free, dialin number, 1–866–659–0537 and the
passcode is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines,
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
PO 00000
Frm 00051
Fmt 4703
Sfmt 9990
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and
will expire on September 30, 2017.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters for Discussion: The agenda for
the conference call includes: Reporting
Final SEC Petition Vote Count from
November ABRWH Meeting for Area IV
of Santa Susanna Field Laboratory
(Ventura County, CA); Follow-up on
Hooker Site Profile Review; Work Group
and Subcommittee Reports; Status of
SEC Petitions Update; Plans for the
March 2017 Advisory Board Meeting;
and Advisory Board Correspondence.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Theodore M. Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road
NE., Mailstop: E–20, Atlanta, GA 30329,
Telephone (513)533–6800, Toll Free 1–
800–CDC–INFO, Email ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–30519 Filed 12–19–16; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)]
[Notices]
[Page 92820]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30523]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Infectious Diseases
(BSC, OID)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 11:00 a.m.-1:00 p.m., EST, January 23, 2017.
Place: Teleconference.
Status: The meeting is open to the public; the toll free dial in
number is 1-877-951-7311 with a pass code of 4530516.
Purpose: The BSC, OID, provides advice and guidance to the
Secretary, Department of Health and Human Services; the Director, CDC;
the Director, OID; and the Directors of the National Center for
Immunization and Respiratory Diseases, the National Center for Emerging
and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas:
Strategies, goals, and priorities for programs; research within the
national centers; and overall strategic direction and focus of OID and
the national centers.
Matters for Discussion: Topics to be discussed during the
teleconference include (1) discussion and vote on the Food Safety
Modernization Act Surveillance Working Group Annual Report to the
Secretary of Health and Human Services and (2) a report back from a
recent external review of CDC's advanced molecular detection
activities.
The agenda and any supplemental material will be available at
www.cdc.gov/oid/BSC/meetingschedule.html after January 16.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Robin Moseley, M.A.T.,
Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop
D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-30523 Filed 12-19-16; 8:45 am]
BILLING CODE 4163-18-P
